Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who wrote (1035)	5/2/2000 1:28:00 PM
From: Biomaven	Read Replies (4) of 52153

GZTC today announced a deal with MEDX to produce a protein. Might help cement the Genomics->lots of targets->lots of Mabs->lots of goats chain. Some smart operators figured out the first part of this chain early last year and made themselves a packet in ABGX/MEDX/PDLI. If GZTC can just deliver with a single approved drug, then the last link of the chain should prove profitable for GZTC investors as well. Anyone heard a "plantibody" update lately? This seems like one way this chain might eventually break, but looks like it's still a good few years off. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next